Abstract
In an open multicentre drug monitoring survey, 1611 patients with atopic dermatitis, contact eczema, dry eczema, psoriasis and pruritus were treated with a preparation containing 5% urea and 3% polidocanol (laurylmacrogol). To monitor the course of treatment, three examinations were performed, one at the start of therapy and two more at intervals of approximately two weeks. A marked improvement in the status of the skin was observed during treatment. A marked regression occurred in the principal signs of dry skin--scaling, dryness and roughness. Troublesome itching was also greatly reduced. Almost half of the patients (48.9%) were free of itching at the end of the observation period. Adverse drug effects arose in only 2.8% of cases, and were mostly smarting, itching and irritation. No intolerance reactions were observed in children under six years. At the end of the observation period the skin status was judged, by both the doctors and the patients as 'good' or 'very good' in almost 90% of cases. Furthermore, the assessment with regard to the regression of itching was almost identical.
Citations
Dec 15, 2010·Clinics in Dermatology·Adam ReichJacek C Szepietowski
May 2, 2015·Clinical Reviews in Allergy & Immunology·Nicholas K MollanazarGil Yosipovitch
Jul 14, 2005·Toxicology·Claudia Fruijtier-Pölloth
Apr 17, 2017·Journal of the American Academy of Dermatology·Helena KuhnGeorge Kroumpouzos
May 23, 2008·International Journal of Cosmetic Science·G Yosipovitch
Jul 11, 2018·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matthias AugustinPetra Staubach
Jul 20, 2011·Seminars in Cutaneous Medicine and Surgery·Sarina B Elmariah, Ethan A Lerner
Dec 30, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas WerfelUNKNOWN Association of Scientific Medical Societies of Germany
Jan 26, 2020·The Cochrane Database of Systematic Reviews·Andrea AndradeJuan Va Franco
Feb 18, 2020·Expert Opinion on Drug Safety·Kayla Fourzali, Gil Yosipovitch
Aug 23, 2003·The British Journal of Dermatology·Y Ashida, M Denda
Dec 30, 2017·American Journal of Clinical Dermatology·Janelle Pavlis, Gil Yosipovitch
Nov 19, 2019·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Matthias AugustinPetra Staubach
Apr 30, 2010·Expert Opinion on Pharmacotherapy·Tejesh Patel, Gil Yosipovitch
Jan 8, 2021·Clinical, Cosmetic and Investigational Dermatology·Marco ArdigòMassimo Milani
Nov 22, 2020·Actas dermo-sifiliográficas·E Abarca LachénY Gilaberte Calzada
Feb 19, 2021·Skin Pharmacology and Physiology·Marika QuadriAlessandra Marconi